Clincosm LogoSign in Get a demo

intrahepatic cholangiocarcinoma

Showing 51 - 75 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (Camrelizumab, Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Guangzhou, Guangdong, China
    Li Xu
Dec 8, 2021

Intrahepatic Cholangiocarcinoma Trial in Xi'an (lymphadenectomy)

Completed
  • Intrahepatic Cholangiocarcinoma
  • lymphadenectomy
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Xi'an Jiaotong University
Dec 7, 2021

Intrahepatic Cholangiocarcinoma Trial in Charleston (SIR-Spheres microspheres (Yttrium-90 Microspheres), Gemcitabine, Cisplatin)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • SIR-Spheres microspheres (Yttrium-90 Microspheres)
  • +2 more
  • Charleston, South Carolina
    Medical University of South Carolina
Nov 11, 2021

Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma Trial in Hangzhou (Irinotecan

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • +3 more
  • Irinotecan Liposome Injection
  • +3 more
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Sep 16, 2021

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Sintilimab, Lenvatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 23, 2021

Intrahepatic Cholangiocarcinoma Trial in Shanghai (cryoablation, Sintilimab, lenvatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 23, 2021

Metastatic Colon Cancer, Liver Cancer, Intrahepatic Cholangiocarcinoma Trial (Medtronic Synchromed II pump)

Withdrawn
  • Metastatic Colon Cancer
  • +2 more
  • Medtronic Synchromed II pump
  • (no location specified)
Jul 13, 2021

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Tislelizumab, TACE)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 13, 2021

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (oxaliplatin , fluorouracil, and leucovorin, gemcitabine and cisplatin)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • oxaliplatin , fluorouracil, and leucovorin
  • gemcitabine and cisplatin
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Jul 7, 2021

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Gemox combimed PD1 antibody)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Gemox combimed PD1 antibody
  • Shanghai, Shanghai, China
    Zhongshan hospital
Jul 7, 2021

Intrahepatic Cholangiocarcinoma, PD1 Antibody, Lenvatinib Trial in Shanghai (Neoadjuvant treatment)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • +3 more
  • Neoadjuvant treatment
  • Shanghai, Shanghai, China
    Zhongshan hospital
Jul 5, 2021

Intrahepatic Cholangiocarcinoma Trial (Famitinib)

Withdrawn
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Jun 16, 2021

Intrahepatic Cholangiocarcinoma, Transarterial Chemoembolization, Apatinib Trial in Chengdu (DEB-TACE combined with apatinib and

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • +3 more
  • DEB-TACE combined with apatinib and PD-1 antibody
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital and Research Institute
Apr 4, 2021

Intrahepatic Cholangiocarcinoma, Second-line Treatment Trial in Beijing (Apatinib)

Completed
  • Intrahepatic Cholangiocarcinoma
  • Second-line Treatment
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 30, 2020

Intrahepatic Cholangiocarcinoma Trial in Shanghai (PD-1 blocking antibody SHR-1210, Capecitabine)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    180 Fenglin Road
Sep 26, 2020

Intrahepatic Cholangiocarcinoma, Peripheral Cholangiocarcinoma, Cholangiolar Carcinoma Trial in United States (Liver resection

Completed
  • Intrahepatic Cholangiocarcinoma
  • +3 more
  • Liver resection and placement of hepatic artery infusion pump
  • +3 more
  • Basking Ridge, New Jersey
  • +4 more
Sep 10, 2020

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (Lenvatinib)

Withdrawn
  • Intrahepatic Cholangiocarcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 19, 2020

Liver Metastases, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Saint Louis (Stereotactic body

Completed
Has Results
  • Liver Metastases
  • +2 more
  • Stereotactic body radiosurgery
  • Stereotactic Body Radiotherapy
  • Saint Louis, Missouri
    St. John's Mercy Medical Center
Feb 19, 2020

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (irinotecan, oxaliplatin , fluorouracil, and leucovorin, gemcitabine and

Unknown status
  • Intrahepatic Cholangiocarcinoma
  • irinotecan, oxaliplatin , fluorouracil, and leucovorin
  • gemcitabine and oxaliplatin
  • Guangzhou, Guangdong, China
  • +1 more
Dec 3, 2019

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (Lenvatinib, PD-1 antibody)

Suspended
  • Intrahepatic Cholangiocarcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Jan 25, 2019

Intrahepatic Cholangiocarcinoma Trial in Minneapolis (Gemcitabine, Cisplatin, low dose radiotherapy)

Terminated
Has Results
  • Intrahepatic Cholangiocarcinoma
  • Minneapolis, Minnesota
    Virginia Piper Cancer Institute
Oct 2, 2018

Intrahepatic Cholangiocarcinoma Trial in Hangzhou (MUC-1 CART cell immunotherapy)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • MUC-1 CART cell immunotherapy
  • Hangzhou, Zhejiang, China
    The second affiliated hospital of Zhejiang University
Aug 20, 2018

Intrahepatic Cholangiocarcinoma Trial in Zhengzhou (Apatinib)

Unknown status
  • Intrahepatic Cholangiocarcinoma
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
May 9, 2018

Intrahepatic Cholangiocarcinoma Trial in Louisville (Carboplatin, Cisplatin, Gemcitabine)

Withdrawn
  • Intrahepatic Cholangiocarcinoma
  • Louisville, Kentucky
    University of Louisville
Feb 15, 2018

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Bortezomib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Easter hepatobiliary surgery hospital
Nov 15, 2017